Disposition of 412584 shares by Sukhatme Mayukh of Roivant Sciences at 3.85 subject to Rule 16b-3
ROIV Stock | USD 12.00 0.03 0.25% |
Slightly above 56% of all Roivant Sciences' sophisticated investors are looking to take a long position. The analysis of the overall investor sentiment regarding Roivant Sciences suggests that some traders are interested. Roivant Sciences' investing sentiment can be driven by a variety of factors including economic data, Roivant Sciences' earnings reports, geopolitical events, and overall market trends.
Roivant |
Filed transaction by Roivant Sciences Director, Officer: Pres&chief Investment Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Read at macroaxis.com
Cash Flow Correlation
Roivant Sciences' cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Roivant Sciences' relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.Click cells to compare fundamentals
Roivant Sciences Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Roivant Sciences can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Roivant Sciences Fundamental Analysis
We analyze Roivant Sciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Roivant Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Roivant Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Return On Asset
Return On Asset Comparative Analysis
Roivant Sciences is currently under evaluation in return on asset category among its peers. Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Roivant Sciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Roivant Sciences stock to make a market-neutral strategy. Peer analysis of Roivant Sciences could also be used in its relative valuation, which is a method of valuing Roivant Sciences by comparing valuation metrics with similar companies.
Peers
Roivant Sciences Related Equities
CGEM | Cullinan Oncology | 3.37 | ||||
BGNE | BeiGene | 2.21 | ||||
VRDN | Viridian Therapeutics | 1.47 | ||||
PLRX | Pliant Therapeutics | 1.12 | ||||
RVMD | Revolution Medicines | 0.75 | ||||
AKRO | Akero Therapeutics | 0.67 | ||||
APLS | Apellis Pharmaceuticals | 0.33 | ||||
BPMC | Blueprint Medicines | 0.14 | ||||
DAWN | Day One | 0.16 | ||||
ASND | Ascendis Pharma | 0.65 | ||||
KRYS | Krystal Biotech | 1.44 | ||||
PHAT | Phathom Pharmaceuticals | 1.45 | ||||
SNDX | Syndax Pharmaceuticals | 1.80 | ||||
INZY | Inozyme Pharma | 2.66 | ||||
LYRA | Lyra Therapeutics | 4.28 |
Additional Tools for Roivant Stock Analysis
When running Roivant Sciences' price analysis, check to measure Roivant Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Roivant Sciences is operating at the current time. Most of Roivant Sciences' value examination focuses on studying past and present price action to predict the probability of Roivant Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Roivant Sciences' price. Additionally, you may evaluate how the addition of Roivant Sciences to your portfolios can decrease your overall portfolio volatility.